granted patent: Chimeric antisense oligonucleotides of arabinofuranose analogue and deoxyribose nucleotides

TitleChimeric antisense oligonucleotides of arabinofuranose analogue and deoxyribose nucleotides
Granted PatentUS 8178348
Granted Date2012-05-15
Priority Date2001-09-04 PCT/CA2001001252
2000-09-06 US 09/230414P
Inventors
Issue Date30-Nov-2012
Citation
US Patent US 8178348. Washington, DC: US Patent and Trademark Office (USPTO), 2012 How to Cite?
AbstractThe present invention relates to novel oligonucleotide chimera used as therapeutic agents to selectively prevent gene transcription and expression in a sequence-specific manner. In particular, this invention is directed to the selective inhibition of protein biosynthesis via antisense strategy using oligonucleotides constructed from arabinonucleotide or modified arabinonucleotide residues, flanking a series of deoxyribose nucleotide residues of variable length. Particularly this invention relates to the use of antisense oligonucleotides constructed from arabinonucleotide or modified arabinonucleotide residues, flanking a series of deoxyribose nucleotide residues of variable length, to hybridize to complementary RNA such as cellular messenger RNA, viral RNA, etc.; More particularly this invention relates to the use of antisense oligonucleotides constructed from arabinonucleotide or modified arabinonucleotide residues, flanking a series of deoxyribose nucleotide residues of variable length, to hybridize to and induce cleavage of (via RNaseH activation) the complementary RNA.
Persistent Identifierhttp://hdl.handle.net/10722/177048
References

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:39:00Z-
dc.date.available2012-11-30T08:39:00Z-
dc.date.issued2012-11-30-
dc.identifier.citationUS Patent US 8178348. Washington, DC: US Patent and Trademark Office (USPTO), 2012en_HK
dc.identifier.urihttp://hdl.handle.net/10722/177048-
dc.description.abstractThe present invention relates to novel oligonucleotide chimera used as therapeutic agents to selectively prevent gene transcription and expression in a sequence-specific manner. In particular, this invention is directed to the selective inhibition of protein biosynthesis via antisense strategy using oligonucleotides constructed from arabinonucleotide or modified arabinonucleotide residues, flanking a series of deoxyribose nucleotide residues of variable length. Particularly this invention relates to the use of antisense oligonucleotides constructed from arabinonucleotide or modified arabinonucleotide residues, flanking a series of deoxyribose nucleotide residues of variable length, to hybridize to complementary RNA such as cellular messenger RNA, viral RNA, etc.; More particularly this invention relates to the use of antisense oligonucleotides constructed from arabinonucleotide or modified arabinonucleotide residues, flanking a series of deoxyribose nucleotide residues of variable length, to hybridize to and induce cleavage of (via RNaseH activation) the complementary RNA.en_HK
dc.titleChimeric antisense oligonucleotides of arabinofuranose analogue and deoxyribose nucleotidesen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorDamha Masad Joseen_HK
dc.contributor.inventorParniak Michael Aen_HK
dc.contributor.inventorLok, CNen_HK
dc.contributor.inventorViazovkina Ekaterinaen_HK
patents.identifier.applicationUS 10/363768en_HK
patents.identifier.grantedUS 8178348en_HK
patents.description.assigneeUNIV MCGILL [CA]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.granted2012-05-15en_HK
dc.relation.referencesUS 5808040 (A) 1998-09-15en_HK
dc.relation.referencesUS 5955589 (A) 1999-09-21en_HK
dc.relation.referencesUS 5968748 (A) 1999-10-19en_HK
dc.relation.referencesWO 9950409 (A9) 2000-07-20en_HK
dc.relation.referencesWO 9950409 (A1) 1999-10-07en_HK
dc.relation.referencesWO 9967378 (A1) 1999-12-29en_HK
dc.relation.referencesWO 9967378 (A1) 1999-12-29en_HK
patents.date.application2003-06-13en_HK
patents.date.priority2001-09-04 PCT/CA2001001252en_HK
patents.date.priority2000-09-06 US 09/230414Pen_HK
patents.description.ccUSen_HK
patents.relation.familyAT 293688 (T) 2005-05-15en_HK
patents.relation.familyAU 8944801 (A) 2002-03-22en_HK
patents.relation.familyAU 2001289448 (B2) 2006-03-16en_HK
patents.relation.familyCA 2419563 (A1) 2002-03-14en_HK
patents.relation.familyDE 60110244 (T2) 2006-01-19en_HK
patents.relation.familyEP 1315807 (A2) 2003-06-04en_HK
patents.relation.familyJP 2004507272 (A) 2004-03-11en_HK
patents.relation.familyUS 2004038399 (A1) 2004-02-26en_HK
patents.relation.familyUS 8178348 (B2) 2012-05-15en_HK
patents.relation.familyWO 0220773 (A2) 2002-03-14en_HK
patents.description.kindB2en_HK
patents.typePatent_granteden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats